MCTC Holdings Inc. (MCTC) to Strengthen Financial and Strategic Planning Focus After Appointing Cannabis Industry Veteran as New CFO
- The company has filed six patents on hemp extract technologies and delivery systems
- Expanding on development of infusion technologies to include exotic cannabinoids that may improve sleep and control appetite
- Industrial hemp market is expected to grow to $26.6 billion by 2025
Hemp infusion technology innovator MCTC Holdings Inc. (OTC: MCTC) appointed cannabis industry veteran Robert L. Hymers III as its chief financial officer. Previously a director of the company, Hymers has a vast and impressive background in financial planning and analysis, corporate finance, treasury, tax, investor relations, risk management, and strategic planning, according to a company press release (http://nnw.fm/OzIP7).
Previously, Hymers was CFO and Director of Marijuana Company of America, Inc. (OTCQB: MCOA), and brings with him a deep understanding of the hemp and cannabis industries. MCTC and Marijuana Company of America have signed a distribution contract for MCTC’s Hemp You Can Feel(TM) beverage product line, a patent-pending, organic, ultra-clean label line of CBD powdered drink and hemp extract mixes (http://nnw.fm/oTy58).
According to MCTC CEO Arman Tabatabaei, the new appointment will significantly strengthen the company. Hymers “brings a unique combination of financial knowledge, executive insight and managerial talent that will help us not only in financial reporting and compliance, but also relative to both strategic planning and tactical execution,” as Tabatabaei noted in a news release.
On occasion of the appointment, Hymers commented that MCTC is bringing unique intellectual property to the cannabis and hemp extract marketplaces and beginning to introduce highly innovative products based on the company’s intellectual property. “It’s an exciting time in the marketplace and I am looking forward to helping the Company achieve its objectives while seeking to maximize shareholder value,” he added.
MCTC Holdings, which has announced a pending name change to Cannabis Global, is poised to take advantage of opportunities in the cannabis industry while avoiding overcrowded and potentially problematic niches like retail and cultivation. The company was reorganized in June 2019 and its rebranding has focused on developing unique cannabis-related intellectual properties, products and technologies. The company aims to process hemp isolates, distillates, and other refined products using special patent-pending delivery systems and sell them through food, beverage and consumer brands.
Through 2020, the company plans to conduct trials on exotic and lesser-known cannabinoids like cannabinol (CBN) and THC-V, including their potential effects on appetite suppression.
MCTC Holdings recently filed six patents, of which its fourth cannabinoid delivery technology patent is the most important for cannabinoid delivery systems. This patent broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium (http://nnw.fm/kfP7O).
As an integrated cannabis business operation and cannabinoid science innovator, MCTC Holdings is primarily focused on high-growth and high-margin sub-sectors of the cannabis and hemp industry, including multiple growing verticals in the global cannabis and industrial hemp markets via acquisitions, partnerships and the development of new intellectual property. According to a Research and Markets report, the global industrial hemp market is poised to grow exponentially, from $4.6 billion in 2019 to $26.6 billion by 2025, recording a CAGR of 34% (http://nnw.fm/55Aou).
For more information, visit the company’s website at www.CannabisGlobalInc.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- The company has filed six patents on hemp extract technologies and delivery systems
- Expanding on development of infusion technologies to include exotic cannabinoids that may improve sleep and control appetite
- Industrial hemp market is expected to grow to $26.6 billion by 2025
Hemp infusion technology innovator MCTC Holdings Inc. (OTC: MCTC) appointed cannabis industry veteran Robert L. Hymers III as its chief financial officer. Previously a director of the company, Hymers has a vast and impressive background in financial planning and analysis, corporate finance, treasury, tax, investor relations, risk management, and strategic planning, according to a company press release (http://nnw.fm/OzIP7).
Previously, Hymers was CFO and Director of Marijuana Company of America, Inc. (OTCQB: MCOA), and brings with him a deep understanding of the hemp and cannabis industries. MCTC and Marijuana Company of America have signed a distribution contract for MCTC’s Hemp You Can Feel(TM) beverage product line, a patent-pending, organic, ultra-clean label line of CBD powdered drink and hemp extract mixes (http://nnw.fm/oTy58).
According to MCTC CEO Arman Tabatabaei, the new appointment will significantly strengthen the company. Hymers “brings a unique combination of financial knowledge, executive insight and managerial talent that will help us not only in financial reporting and compliance, but also relative to both strategic planning and tactical execution,” as Tabatabaei noted in a news release.
On occasion of the appointment, Hymers commented that MCTC is bringing unique intellectual property to the cannabis and hemp extract marketplaces and beginning to introduce highly innovative products based on the company’s intellectual property. “It’s an exciting time in the marketplace and I am looking forward to helping the Company achieve its objectives while seeking to maximize shareholder value,” he added.
MCTC Holdings, which has announced a pending name change to Cannabis Global, is poised to take advantage of opportunities in the cannabis industry while avoiding overcrowded and potentially problematic niches like retail and cultivation. The company was reorganized in June 2019 and its rebranding has focused on developing unique cannabis-related intellectual properties, products and technologies. The company aims to process hemp isolates, distillates, and other refined products using special patent-pending delivery systems and sell them through food, beverage and consumer brands.
Through 2020, the company plans to conduct trials on exotic and lesser-known cannabinoids like cannabinol (CBN) and THC-V, including their potential effects on appetite suppression.
MCTC Holdings recently filed six patents, of which its fourth cannabinoid delivery technology patent is the most important for cannabinoid delivery systems. This patent broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium (http://nnw.fm/kfP7O).
As an integrated cannabis business operation and cannabinoid science innovator, MCTC Holdings is primarily focused on high-growth and high-margin sub-sectors of the cannabis and hemp industry, including multiple growing verticals in the global cannabis and industrial hemp markets via acquisitions, partnerships and the development of new intellectual property. According to a Research and Markets report, the global industrial hemp market is poised to grow exponentially, from $4.6 billion in 2019 to $26.6 billion by 2025, recording a CAGR of 34% (http://nnw.fm/55Aou).
For more information, visit the company’s website at www.CannabisGlobalInc.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
